University of Birmingham researchers have developed a new COVID-19 test that reduces testing time from 30 minutes to less than 5 and delivers accurate results.
Cancer Research UK has announced the appointment of Professor Pamela Kearns, Director of the University of Birmingham's Institute of Cancer and Genomic Sciences, as a Trustee and Member.
A new study has found that an imbalance of the body's oxygen could be the reason why gum disease and chronic kidney disease affect each other.
Dr James Guggenheim has been appointed as a Birmingham Fellow with the Institute of Cardiovascular Sciences at the University of Birmingham.
Findings from an international group of researchers reveal important changes that occur in the thymus to prevent miscarriages and gestational diabetes.
A study of more than 23,000 samples carried out by teams across the UK, including the University of Birmingham, shows Oxford Nanopore's COVID-19 test, LamPORE, is highly accurate for the detection of SARS-CoV-2.
A third of all babies and half of Black, Asian and Minority Ethnic (BAME) babies are vitamin D deficient, a large study of 3000 newborns in the West Midlands has shown.
Funded by the National Institute for Health Research (NIHR) and the Department of Health & Social Care, DaRe2THINK will develop an entirely new way to run large clinical trials for patient benefit in the NHS.
An international team of scientists and engineers have been awarded a grant of £768K by UKRI as part of the Newton Fund's Agile Response Call to develop high performance, low cost ventilators.
An international trial providing one of the lead investigators has identified a potential drug therapy to reverse non-alcoholic fatty liver disease – a condition for which there is currently no approved treatment.
A new and less invasive treatment developed by Cancer Research UK researchers is safer than standard major surgery for early-stage rectal cancer.
The first national study of children with cancer who test positive from COVID-19 has found that they are not at any increased risk of severe COVID-19 infection.